[HTML][HTML] Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients

D Fujimoto, K Uehara, Y Sato, I Sakanoue, M Ito… - Scientific reports, 2017 - nature.com
Concurrent chemoradiation therapy (CCRT) is the treatment of choice for locally advanced
non-small cell lung cancer (LA-NSCLC). Several clinical trials that combine programmed cell …

Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacity

…, T Morimoto, K Uehara, K Nagata, I Sakanoue… - …, 2017 - Wiley Online Library
Background and objective Ground glass nodules ( GGNs ) are frequently encountered in
the lungs. We report the natural history and characteristics of multiple GGNs , and propose a …

[HTML][HTML] Expert consensus on perioperative treatment for non-small cell lung cancer

…, DH Owen, M Rodriguez, I Sakanoue… - Translational Lung …, 2022 - ncbi.nlm.nih.gov
Ichiro Sakanoue: Because of our current status stated above, I do not have a definitive
answer for this question. However, based on the results from the ADAURA trial, I would prefer …

[HTML][HTML] Efficacy and safety of thoracoscopic pericardial window in patients with pericardial effusions: a single-center case series

I Sakanoue, H Hamakawa, Y Okubo, K Minami… - Journal of cardiothoracic …, 2016 - Springer
Background Pericardial effusion (PE) is a common finding in patients who had chronic
cardiac failure, who had undergone cardiac surgery, or who had certain other benign and …

Comparison of PD-L1 assays in non-small cell lung cancer: 22C3 pharmDx and SP263

…, R Tachikawa, N Date, I Sakanoue… - Anticancer …, 2018 - ar.iiarjournals.org
Background/Aim: While the PD-L1 22C3 pharmDx assay is an FDA-approved diagnostic
assay for pembrolizumab use, not every pathology laboratory has the Dako Autostainer to use …

A CLUE for better assessment of donor lungs: novel technique in clinical ex vivo lung perfusion

KS Ayyat, T Okamoto, H Niikawa, I Sakanoue… - The Journal of Heart and …, 2020 - Elsevier
BACKGROUND The direCt Lung Ultrasound Evaluation (CLUE) technique was proven to be
an accurate method for monitoring extravascular lung water in donor lungs during ex vivo …

[HTML][HTML] Real-time lung weight measurement during cellular ex vivo lung perfusion: An early predictor of transplant suitability

R Kosaka, D Sakota, I Sakanoue, H Niikawa… - …, 2023 - journals.lww.com
Background. Increased extravascular lung water during ex vivo lung perfusion (EVLP) is
associated with ischemia reperfusion injury and poor pulmonary function. A non-invasive …

Reduced tumour proportion scores for programmed cell death ligand 1 in stored paraffin tissue sections

…, A Nakagawa, K Otsuka, I Sakanoue… - Anticancer …, 2018 - ar.iiarjournals.org
Background/Aim: We evaluated the effects of storage of formalin-fixed, paraffin-embedded (FFPE)
sections on the tumour proportion score (TPS) for programmed cell death ligand 1 (PD-…

Prone ex vivo lung perfusion protects human lungs from reperfusion injury

…, T Okamoto, KS Ayyat, Y Itoda, I Sakanoue… - Artificial …, 2022 - Wiley Online Library
Background We previously reported beneficial effects of prone positioning during ex vivo
lung perfusion (EVLP) using porcine lungs. In this study, we sought to determine if prone …

[HTML][HTML] KRAS mutation-positive mucinous adenocarcinoma originating in the thymus

I Sakanoue, H Hamakawa, D Fujimoto… - Journal of Thoracic …, 2017 - ncbi.nlm.nih.gov
Thymic carcinoma is a rare, aggressive disease with a low 5-year survival rate. The most
common histological neoplastic thymic tumor subtype is squamous cell. We describe an …